Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF JULY 13, 2019 FBO #6441
SOLICITATION NOTICE

68 -- Pigment orange 13 [Bisphenly-14C(U)]

Notice Date
7/11/2019
 
Notice Type
Combine Synopsis/Solicitation
 
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
 
Contracting Office
3900 NCTR Road, HFT-320 Bldg 50 | Rm 421 Jefferson AR 72079
 
ZIP Code
72079
 
Solicitation Number
FDA-SOL-1217056
 
Response Due
7/22/2019
 
Point of Contact
ROOSEVELT D. WALKER, CONTRACT SPECIALIST, Phone 8705437405
 
E-Mail Address
roosevelt.walker@fda.hhs.gov
 
Small Business Set-Aside
Total Small Business
 
Description
This is a combined synopsis/solicitation for commercial items prepared in accordance with the Federal Acquisition Regulation (FAR) format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. It is the Government's intent to issue a Firm Fixed Priced Purchase Order in accordance with FAR Part 13. The solicitation number is FDA_SOL_1217056. This solicitation is issued as a Request for Quote (RFQ). The solicitation document and incorporated provisions and clauses in effect through the Federal Acquisition Circular 2019-01 dated January 22,2019. The appropriate North American Industry Classification System (NAICS) Code is 325413 Diagnostic Substance. The Small Business Size standard is 1,250 employees. This requirement is solicited as a Total Set-aside for Small Business competition. Statement of Work The FDA/NCTR/OR/DBT requires Pigment orange 13 [Bisphenly-14C(U)] for research on tattoos pigments in pregnant female SKH-1 mice. The highest prevalence of tattooing has been shown to be in of women of childbearing years. While thought to permanent, it has been noted some pigments in tattoos begin to fade which suggest the pigments are either decomposing or migrating in the body. One of the pigments to be studied is Pigment Orange 13, to track the pigment and its possible breakdown products, post tattooing. The dorsal skin of pregnant mice will be tattooed with the 14C-Pigment Orange 13 and placed in metabolic cages for the collection of urine and feces. After specified gestation period, the animals will be sacrificed, tissues harvested and analyzed for to determine location and quantitation of 14C present. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (11-JUL-2019); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
 
Web Link
Link To Document
(https://www.fbo.gov/spg/HHS/FDA/NCTR/FDA-SOL-1217056/listing.html)
 
Place of Performance
Address: US Food and Drug Administration National Center for Toxicological Research (NCTR) 3900 NCTR RD, Jefferson, AR 72079 Jefferson, AR
Zip Code: 720709
Country: US
 
Record
SN05367237-F 20190713/190711230052 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.